These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 7907918)

  • 61. Lymphocytes infiltrating human ovarian tumors. I. Role of Leu-19 (NKH1)-positive recombinant IL-2-activated cultures of lymphocytes infiltrating human ovarian tumors.
    Heo DS; Whiteside TL; Kanbour A; Herberman RB
    J Immunol; 1988 Jun; 140(11):4042-9. PubMed ID: 3286766
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The effects of granulocyte-macrophage colony-stimulating factor on tumour-infiltrating lymphocytes from renal cell carcinoma.
    Steger GG; Kaboo R; deKernion JB; Figlin R; Belldegrun A
    Br J Cancer; 1995 Jul; 72(1):101-7. PubMed ID: 7599037
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A correlation between the expression of CD 8 antigen and specific cytotoxicity of tumor-infiltrating lymphocytes.
    Okada Y; Yahata G; Takeuchi S; Seidoh T; Tanaka K
    Jpn J Cancer Res; 1989 Mar; 80(3):249-56. PubMed ID: 2524461
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Restoration of tumor specific human leukocyte antigens class I-restricted cytotoxicity by dendritic cell stimulation of tumor infiltrating lymphocytes in patients with advanced ovarian cancer.
    Santin AD; Bellone S; Palmieri M; Bossini B; Cane' S; Bignotti E; Roman JJ; Cannon MJ; Pecorelli S
    Int J Gynecol Cancer; 2004; 14(1):64-75. PubMed ID: 14764031
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Mouse CD8+ CD122+ T cells with intermediate TCR increasing with age provide a source of early IFN-gamma production.
    Takayama E; Seki S; Ohkawa T; Ami K; Habu Y; Yamaguchi T; Tadakuma T; Hiraide H
    J Immunol; 2000 Jun; 164(11):5652-8. PubMed ID: 10820240
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Differential effects of interleukin-2 and CD3 triggering on cytokine gene transcription and secretion in cultured tumor infiltrating lymphocytes.
    Filgueira L; Zuber M; Juretic A; Lüscher U; Caetano V; Harder F; Garotta G; Heberer M; Spagnoli GC
    Cell Immunol; 1993 Aug; 150(1):205-18. PubMed ID: 8343966
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Tumour-infiltrating lymphocytes mediate lysis of autologous squamous cell carcinomas of the head and neck.
    Hald J; Rasmussen N; Claesson MH
    Cancer Immunol Immunother; 1995 Oct; 41(4):243-50. PubMed ID: 7489567
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cytokine production by T-cell lines derived from tumor-infiltrating lymphocytes from patients with ovarian carcinoma: tumor-specific immune responses and inhibition of antigen-independent cytokine production by ovarian tumor cells.
    Kooi S; Freedman RS; Rodriguez-Villanueva J; Platsoucas CD
    Lymphokine Cytokine Res; 1993 Dec; 12(6):429-37. PubMed ID: 8123759
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
    Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
    Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Renal-cell carcinoma-specific lysis by cytotoxic T-lymphocyte clones isolated from peripheral blood lymphocytes and tumor-infiltrating lymphocytes.
    Brouwenstijn N; Gaugler B; Krüse KM; van der Spek CW; Mulder A; Osanto S; van den Eynde BJ; Schrier PI
    Int J Cancer; 1996 Oct; 68(2):177-82. PubMed ID: 8900424
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Increase in the capability of interleukin 2 gene-transduced renal cell carcinoma cells to induce cytotoxic lymphocytes.
    Itoh K; Umezu Y; Morita T; Saya H; Seito D; Augustus LB; Nakao M; Sakata M; Miyajima J; Masuoka K
    Kurume Med J; 1994; 41(2):53-63. PubMed ID: 7967440
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Culture of tumour-infiltrating lymphocytes from melanoma and colon carcinoma: removal of tumour cells does not affect tumour-specificity.
    Mulder WM; Stukart MJ; Roos M; van Lier RA; Wagstaff J; Scheper RJ; Bloemena E
    Cancer Immunol Immunother; 1995 Nov; 41(5):293-301. PubMed ID: 8536275
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Presentation of renal tumor antigens by human dendritic cells activates tumor-infiltrating lymphocytes against autologous tumor: implications for live kidney cancer vaccines.
    Mulders P; Tso CL; Gitlitz B; Kaboo R; Hinkel A; Frand S; Kiertscher S; Roth MD; deKernion J; Figlin R; Belldegrun A
    Clin Cancer Res; 1999 Feb; 5(2):445-54. PubMed ID: 10037196
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cytotoxic potential despite impaired activation pathways in T lymphocytes infiltrating nasopharyngeal carcinoma.
    Ferradini L; Miescher S; Stoeck M; Busson P; Barras C; Cerf-Bensussan N; Lipinski M; von Fliedner V; Tursz T
    Int J Cancer; 1991 Feb; 47(3):362-70. PubMed ID: 1899651
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Analysis of T-cell immune response in renal cell carcinoma: polarization to type 1-like differentiation pattern, clonal T-cell expansion and tumor-specific cytotoxicity.
    Angevin E; Kremer F; Gaudin C; Hercend T; Triebel F
    Int J Cancer; 1997 Jul; 72(3):431-40. PubMed ID: 9247286
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Characterization of human autotumor-reactive T-cell clones obtained from tumor-infiltrating lymphocytes in liver metastasis of gastric carcinoma.
    Shimizu Y; Weidmann E; Iwatsuki S; Herberman RB; Whiteside TL
    Cancer Res; 1991 Nov; 51(22):6153-62. PubMed ID: 1718596
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Flow cytometric analysis of tumour-infiltrating lymphocytes in patients with renal cell carcinoma.
    Kowalczyk D; Skorupski W; Kwias Z; Nowak J
    Br J Urol; 1997 Oct; 80(4):543-7. PubMed ID: 9352689
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Heteroconjugate antibody-directed killing of autologous human renal carcinoma cells by in vitro-activated lymphocytes.
    Kerr L; Huntoon C; Donohue J; Leibson PJ; Bander NH; Ghose T; Luner SJ; Vessella R; McKean DJ
    J Immunol; 1990 May; 144(10):4060-7. PubMed ID: 2139677
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Antitumor effector cells in recombinant IL-2 activated tumor infiltrating lymphocytes from human solid cancers].
    Ishii S; Shiiba K; Ebina N; Matsuno S
    Nihon Geka Gakkai Zasshi; 1993 Mar; 94(3):213-24. PubMed ID: 7686244
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Interleukin-12 augments the generation of autologous tumor-reactive CD8+ cytotoxic T lymphocytes from tumor-infiltrating lymphocytes.
    Kuge S; Watanabe K; Makino K; Tokuda Y; Mitomi T; Kawamura N; Habu S; Nishimura T
    Jpn J Cancer Res; 1995 Feb; 86(2):135-9. PubMed ID: 7730135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.